Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2 **
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2 ** ; year:2020
ChemBioChem ; (2020)
- Urheber
- DOI
-
10.1002/cbic.202000730
- URN
-
urn:nbn:de:101:1-2021020412584302550645
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schmalohr, Benjamin Franz
- Mustafa, Al‐Hassan M.
- Krämer, Oliver Holger
- Imhof, Diana
Ähnliche Objekte (12)
Histidine and Tyrosine-based Heme-binding Motifs for the Prediction of Heme-Regulated Proteins
Editorial: Targeting bruton tyrosine kinase
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance
Newer Tyrosine Kinase Inhibitors for CML
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mechanism of arsenite-induced activation of heme-regulated inhibitor kinase
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Histidine and Tyrosine-based Heme-binding Motifs for the Prediction of Heme-Regulated Proteins
Editorial: Targeting bruton tyrosine kinase
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance
Newer Tyrosine Kinase Inhibitors for CML
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mechanism of arsenite-induced activation of heme-regulated inhibitor kinase
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Histidine and Tyrosine-based Heme-binding Motifs for the Prediction of Heme-Regulated Proteins
Editorial: Targeting bruton tyrosine kinase
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance
Newer Tyrosine Kinase Inhibitors for CML
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mechanism of arsenite-induced activation of heme-regulated inhibitor kinase